Bortezomib in Treating Patients With Relapsed or Refractory AIDS-Related Kaposi Sarcoma
Clinical trial NCT01016730 · COMPLETED
Trial details
- NCT number
- NCT01016730
- Sponsor
- National Cancer Institute (NCI)
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2010-01-22
- Primary completion
- 2015-01-07
- Enrollment
- 24
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.